haemopoiesis clinical application dr. tariq m. roshan department of hematology ppsp

42
Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Upload: hester-wilcox

Post on 02-Jan-2016

225 views

Category:

Documents


5 download

TRANSCRIPT

Page 1: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Haemopoiesis Clinical application

Dr. Tariq M. Roshan

Department of Hematology

PPSP

Page 2: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Introduction

Life span

Granulocytes Erythrocytes Platelets Lymphocytes

Page 3: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Introduction

Stem cells Self renewal Plasticity

Progenitor cells Developmentally-restricted cells

Mature cells Mature cell production takes place from the more

developmentally-restricted progenitors

Page 4: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Cell hierarchy (Haemopoiesis schematic representation)

Page 5: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Sites of Haemopoiesis

Yolk sac

Liver and spleen

Bone marrow Gradual replacement

of active (red) marrow by inactive (fatty) tissue

Expansion can occur during increased need for cell production

Page 6: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Stem cells

Self-renewal Normally in G0 phase of cell cycle The capacity for self-reproduction is vastly in

excess of that required to maintain cell production for normal lifetime

As cells increase in number they differentiate as well

Multipotentiality Capacity to generate cells of all the

lymphohaemopoietic lineages

Page 7: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP
Page 8: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Progenitor cells

Encompasses from immediate progeny of stem cells to cells committed to one differentiation lineage

Progenitor cells become progressively more restricted in their differentiation and proliferation capacity

Late progenitor cells eventually restricted to one lineage

Page 9: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Regulation of Haemopoiesis

There should be a balance between cell production and cell death except at the times of requirement

Controlled cell death

Controlled cell production

Page 10: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Regulation of Haemopoiesis

Local environmental controlStromal cell mediated Haemopoiesis

Haemopoietic growth factors (Humoral regulation)Apoptosis

Page 11: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Interaction of stromal cells, growth factors and haemopoietic cells

Page 12: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Local and Humoral regulation of Haemopoiesis

Page 13: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Haemopoietic growth factors

GM-CSF Granulocyte-Macrophage colony stimulating factor

M-CSF Macrophage colony stimulating factor

Erythropoietin Erythropoiesis stimulating hormone

(These factors have the capacity to stimulate the proliferation of their target progenitor cells when used as a sole source of stimulation)

Thrombopoietin Stimulates megakaryopoiesis

Page 14: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Haemopoietic growth factors

Cytokines IL 1 (Interleukin 1) IL 3 IL 4 IL 5 IL 6 IL 9 IL 11 TGF-β SCF (Stem cell factor, also known as kit-ligand)

Cytokines have no (e.g IL-1) or little (SCF) capacity to stimulate cell proliferation on their own, but are able to synergise with other cytokines to recruit nine cells into proliferation

Page 15: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Erythropoiesis and erythrocytes

Lifespan – 120 days

Non nucleated

Biconcave disc

Production regulated by Epo

Needs Fe, B12, folate & other elements for development

Page 16: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP
Page 17: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Functions of erythrocytes

Transport of respiratory gases

Large surface area : volume ratio

Flexible biconcave disc

Haemoglobin for exchange of gases

Capable of glycolysis for the source of energy for cell survival

Page 18: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Erythrocyte disorders

Qualitative Haemoglobin defect

(Anemia, Thalassaemia, sickle cell anemia etc) Membrane & enzyme abnormalities

(G6PD, eliptocytosis, stomato-ovalocytosis)

Quantitative Increased (polycythemia) inherited / acquired Decrease (inherited / acquired hypoplasia) Bleeding

Page 19: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Anaemia

Reduction in circulation haemoglobin

Nutritional deficiency anaemias Iron deficiency B12 & folate deficiency

anaemia Protein deficiency

anaemia Scurvy & other

element deficiency

Iron deficiencyanaemia

B12 & folate deficiency

Page 20: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Nutritional deficiency anaemiaclinical application

Angular Cheilosis

Koilonychia

Glossitis

Marrow iron storesPlummer-Vinsonsyndrome

Page 21: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Anaemia; Globin chain defects

Thalassaemias

Reduced globin chain synthesis

Alpha and Beta chain synthesis defects

Haemoglobinopathies

Abnormal globin chain synthesis

Sickle cell disease

Thalassaemia

Page 22: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Anaemia; Globin chain defects

X-ray appearance ofThalassaemic patient

Hemoglobin electrophoresisfor the diagnosis of thalassaemia

Page 23: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Anaemia; Membrane and enzyme defects Membrane defects

Elliptocytosis Hemolysis

Stomato-ovalocytosis Without haemolysis

Red cell enzymopathies G6PD

Hemolysis after oxidant stress

Blood loss

Elliptocytosis

G6PD deficiency

Page 24: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Anaemia; Reduced bone marrow erythroid Marrow failure Marrow infiltration

Trephine biopsy (AplasticAnemia)

Marrow infiltration Normal trephine

Page 25: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP
Page 26: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Leucocytes

Lymphocytes

Monocytes / Macrophages

Granulocytes Neutrophils Eosinophils Basophils

N

E

B

LM

Band

P

Page 27: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Lymphocytes

Count varies with age

1.5 – 3.5 x109/l The subset cells are

B-cells Antibody mediated

immunity T-cells

Cell mediated immunity

NK cells

Page 28: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Disorders of lymphocytesBenign disorders Lymphocytosis

Viral infections Bacterial infections Protozoal infections

Lymphopenia Marrow failure (drugs, irradiation) Infections (viral infections)

Immune-deficiency syndromes Antibody deficiency Cell mediated immune defiency Combined cell and antibody immune deficiency

Page 29: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Disorders of lymphocytesBenign disorders Infectious

mononucleosis Epstein-Barr virus

infection

Autoimmune lymphoproliferative syndrome

Page 30: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Disorders of LymphocytesMalignant disorders Acute lymphoblastic

leukemia (ALL)

Chronic lymphocytic leukemia (CLL)

Lymphomas Non Hodgkin’s

lymphoma Hodgkin’s disease

ALL

CLL

Page 31: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Monocytes

Count is 0.2-0.8 x 109/l Functions

Antigen presentation Cytokine production Phagocytosis

Page 32: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Disorders of Monocytes

Monocytosis Benign

Chronic bacterial infection

Malignant Chronic Myelomonocytic Leukaemia CMML

Page 33: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Neutrophils

Count 2.5 - 7.5 x 109/l Granular cytoplasm Transient stay in blood Major phagocytic role Bacterial killing 3-5 lobes of nucleus

Page 34: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Disorders of Neutrophil

Neutrophilia Infection (Bacterial) Inflammatory conditions Neoplasia Metabolic conditions

Uraemia Haemorhage / haemolysis Corticosteroids Marrow infiltration

CML

MM M

N

Baso

Page 35: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Disorders of Neutrophil

Neutropenia Count < 1.5 x 109/l Drugs Chemotherapy Viral infection Inherited disorders

Morphological abnormalities Pelger-Huet anomaly May-Hegglin anomaly Chediak-Higashi syndrome

Page 36: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Myeloid malignancies

Acute Myeloid Leukaemia

Chronic Myeloid Leukaemia

Myeloproliferative disorder

Acute Myeloid Leukaemia(AML M-3)

Chronic Myeloid Leukaemia

Page 37: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Eosinophils

Count 0.2 – 0.8 x 109/l

Bilobed nucleus

Phagocytic activity is low

Modulation of hypersensitivity and allergic reactions

Page 38: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Disorders of Eosinophil

Eosinophilia>0.8 x 109/l Allergic reactions Parasitic infections Malignancy

HD, NHL Inflammatory conditions Myeloproliferative disorders Hypereosinophilic syndrome

Page 39: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Basophils

Count 0.1 – 0.2 x 109/l

Bilobed nucleus

Nucleus is hided behind the granules

Inflammatory response

Basophilia is seen in Myeloproliferative disorders (CML)

Page 40: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Platelets

Platelets are fragments of cytoplasm of bone marrow megakaryocytes

Count 150 – 400 x 109/l

Major role in coagulation

Page 41: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Summary

As other rapidly regenerating tissues, the haemopoietic system is organized in hierarchical manner

Better understanding of the factors controlling haemopoiesis is leading a way to better patient care and reconstitution of different lineages, which has been refractory to stimulation efforts previously

Understanding of stem cell physiology & pathology will be essential in the coming years for a hematopathologist

Page 42: Haemopoiesis Clinical application Dr. Tariq M. Roshan Department of Hematology PPSP

Thanks.